Vidipha Central Pharmaceutical JSC (HOSE:VDP)

Revenue by Segment

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2008	FY 2007
Period Ending	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Dec 31, 2008	Dec 31, 2007
Pharmaceuticals	985.64B	934.49B	-		206.95B	191.44B
Pharmaceuticals Growth	5.47%	-	-		8.10%	-
Total	985.64B	934.49B	-		206.95B	191.44B
Total Growth	5.47%	-	-		8.10%	-

Revenue by Geography

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2008	FY 2007
Period Ending	Dec 31, 2025	Jan 1, 2025	Dec 31, 2023	Jan 1, 2023	Dec 31, 2008	Dec 31, 2007
Vietnam	985.64B	934.49B	-		206.95B	191.44B
Vietnam Growth	5.47%	-	-		8.10%	-
Total	985.64B	934.49B	-		206.95B	191.44B
Total Growth	5.47%	-	-		8.10%	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error